|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Rat EPO ORF mammalian expression plasmid, C-GFPSpark tag||RG80055-ACG|
|Rat EPO ORF mammalian expression plasmid, C-OFPSpark / RFP tag||RG80055-ACR|
|Rat EPO ORF mammalian expression plasmid, C-Flag tag||RG80055-CF|
|Rat EPO ORF mammalian expression plasmid, C-His tag||RG80055-CH|
|Rat EPO ORF mammalian expression plasmid, C-Myc tag||RG80055-CM|
|Rat EPO ORF mammalian expression plasmid, C-HA tag||RG80055-CY|
|Rat EPO Gene cDNA clone plasmid||RG80055-M|
|Rat EPO ORF mammalian expression plasmid, N-Flag tag||RG80055-NF|
|Rat EPO ORF mammalian expression plasmid, N-His tag||RG80055-NH|
|Rat EPO ORF mammalian expression plasmid, N-Myc tag||RG80055-NM|
|Rat EPO ORF mammalian expression plasmid, N-HA tag||RG80055-NY|
|Rat EPO natural ORF mammalian expression plasmid||RG80055-UT|
|Learn more about expression Vectors|
Erythropoietin is a member of the EPO / TPO family. It is a secreted, glycosylated cytokine composed of four alpha helical bundles. Erythropoietin can be found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. It also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types. Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass. It is produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals. Genetic variation in erythropoietin is associated with susceptbility to microvascular complications of diabetes type 2. These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. It has a longer circulating half-life in vivo. Erythropoietin is being much misused as a performance-enhancing drug in endurance athletes.